[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354222-105":59,"doc-detail-354222-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ybx1-expression-marks-proliferative-tumour-states-with-context-dependent-genomic-instability-a-pan-cancer-analysis","YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability - A Pan-Cancer Analysis","","Y-box binding protein 1 (YB-1; YBX1) is a multifunctional DNA- and RNA-binding factor involved in cell-cycle control, DNA repair, stress adaptation, and therapy resistance. Across pan-cancer datasets, high YBX1 mRNA expression correlated with conserved transcriptional programs for cell cycle and mitosis, pathway concordance at the protein level, and clinicopathological markers of aggressive disease. Associations with mutation burden and chromosomal alteration largely reflected proliferative activity, particularly G2/M-linked programs. Clinically, elevated YBX1 mRNA and YB-1 protein related to advanced stage, higher grade, and worse survival outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ybx1-expression-marks-proliferative-tumour-states-with-context-dependent-genomic-instability-a-pan-cancer-analysis/354222/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ybx1-expression-marks-proliferative-tumour-states-with-context-dependent-genomic-instability-a-pan-cancer-analysis/354222.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of the pan-cancer analysis of YBX1 and YB-1?","Question",{"text":112,"@type":113},"To determine how YBX1 expression relates to proliferative activity versus genomic instability across diverse tumor types using integrative transcriptomic, proteomic, genomic, and clinical data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does YBX1 expression vary at the genomic and transcriptomic levels?",{"text":117,"@type":113},"YBX1 was rarely altered genomically, while YBX1 mRNA expression showed high variability within tumor cohorts, distinguishing high-expression tumor states.",{"name":119,"@type":110,"acceptedAnswer":120},"Does genomic instability associated with YBX1 reflect an independent program?",{"text":121,"@type":113},"The chromosomal-alteration link was largely attenuated after accounting for proliferative activity, suggesting instability features arise in a context-dependent manner tied to shared proliferative and mitotic biology rather than a standalone instability program.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354222,1790498286,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nYBX1 Expression Marks Proliferative Tumour States with  \nContext-Dependent Genomic Instability: A Pan-Cancer Analysis  \nSelena Wang 1,2, Zahra Shafaei Pishabad 1,2, Debina Sarkar 1,2, Apeksha Arun Bhandarkar 1,2,  \nMakhdoom Sarwar 2,3, Aaron Jeffs 1,2, Glen Reid 1,2, Antony Braithwaite 1,2 and Sunali Mehta 1,2,4, *  \nAcademic Editors: Stergios Boussios, Saak V. Ovsepian and Matin Sheriff  \nReceived: 19 March 2026  \nRevised: 30 April 2026  \nAccepted: 1 May 2026  \nPublished: 13 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pathology and Molecular Medicine, University of Otago, Dunedin 9016, New Zealand;  \n[wanse679@student.otago.ac.nz](wanse679@student.otago.ac.nz) (S.W.); [zahra.shafaei@otago.ac.nz](zahra.shafaei@otago.ac.nz) (Z.S.P.); [debina.sarkar@otago.ac.nz](debina.sarkar@otago.ac.nz) (D.S.);  \n[bhaap437@student.otago.ac.nz](bhaap437@student.otago.ac.nz) (A.A.B.); [aaron.jeffs@otago.ac.nz](aaron.jeffs@otago.ac.nz) (A.J.); [glen.reid@otago.ac.nz](glen.reid@otago.ac.nz) (G.R.);  \n[antony.braithwaite@otago.ac.nz](antony.braithwaite@otago.ac.nz) (A.B.)  \n2 Maurice Wilkins Centre for Biodiscovery, University of Auckland, Auckland 1142, New Zealand; [mak.sarwar@otago.ac.nz](mak.sarwar@otago.ac.nz)  \n3 Department of Obstetrics and Gynaecology, University of Otago, Christchurch 8011, New Zealand  \n4 School of Pharmacy and Biomedical Sciences, The University of Waikato Te Whare Wananga o Waikato, Hamilton 3240, New Zealand  \n* Correspondence: [s.mehta@waikato.ac.nz](s.mehta@waikato.ac.nz); Tel.: +64-7-838-4466  \nAbstract  \nY-box binding protein 1 (YB-1; encoded by YBX1) is a multifunctional DNA-and RNAbinding protein implicated in cell cycle regulation, DNA repair, stress adaptation, and therapy resistance. Elevated YBX1 expression has been associated with aggressive disease across multiple cancer types; however, its pan-cancer genomic and clinical correlates, and the extent to which these reflect proliferative activity versus genomic instability, remain incompletely defined. Here, we performed an integrative pan-cancer analysis across 53 independent datasets spanning 33 tumour types, incorporating transcriptomic (YBX1 mRNA), proteomic (RPPA), genomic, and clinical data. We found that YBX1 is rarely altered at the genomic level, whereas its mRNA expression is highly variable within tumour cohorts. Tumours with high YBX1 mRNA expression consistently exhibited conserved transcriptional programmes enriched for cell cycle, mitotic, RNA processing, and signalling pathways, patterns that were also reflected at the protein level by concordant pathway associations with elevated YB-1 abundance. These molecular features co-occurred with clinicopathological characteristics indicative of aggressive disease. High YBX1 mRNA expression was associated with increased mutation burden, chromosomal alteration burden, hypoxia, and homologous recombination deficiency at the pan-cancer level, with similar molecular associations observed in tumours stratified by elevated YB-1 protein levels. The association between YBX1 expression and chromosomal alteration burden was largely attenuated after accounting for proliferative activity, particularly G2/M-associated transcriptional programmes used as a proxy for mitotic activity. While the relationship with mutation burden was heterogeneous across tumour types, this pattern suggests that links between YBX1 expression and chromosomal instability primarily reflect shared proliferative and mitotic tumour biology rather than an independent genomic instability programme. Clinically, high YBX1 mRNA expression was associated with advanced disease stage, higher histologic grade, reduced progression-free survival, and poorer overall survival. Elevated YB-1 protein levels were also associated with advanced disease stage and poor","cbCaiobVo2QejBHj","https://ap.wps.com/l/cbCaiobVo2QejBHj","pdf",2457611,29,"English","# Introduction\n# Abstract\n## Keywords","[{\"question\":\"What was the goal of the pan-cancer analysis of YBX1 and YB-1?\",\"answer\":\"To determine how YBX1 expression relates to proliferative activity versus genomic instability across diverse tumor types using integrative transcriptomic, proteomic, genomic, and clinical data.\"},{\"question\":\"How does YBX1 expression vary at the genomic and transcriptomic levels?\",\"answer\":\"YBX1 was rarely altered genomically, while YBX1 mRNA expression showed high variability within tumor cohorts, distinguishing high-expression tumor states.\"},{\"question\":\"Does genomic instability associated with YBX1 reflect an independent program?\",\"answer\":\"The chromosomal-alteration link was largely attenuated after accounting for proliferative activity, suggesting instability features arise in a context-dependent manner tied to shared proliferative and mitotic biology rather than a standalone instability program.\"}]","YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability - A Pan-Cancer Analysis | PDF",1790109604,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35efd11ed1ce9ad718adb28ef207e604.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c63bcffff20b31e06751de597e9b483c.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd53cb1463dc442501f72346e76b034d.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df708ea9f5b69a9c4066e6f44fad0430.webp",980,692]